APA (7th ed.) Citation

Theocharopoulos, C., Machairas, N., Ziogas, I. A., Mungo, B., Del Chiaro, M., Glatzounis, G. K., . . . Sotiropoulos, G. C. (2026). Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making. Cancers, 18(1), 94. https://doi.org/10.3390/cancers18010094

Chicago Style (17th ed.) Citation

Theocharopoulos, Charalampos, Nikolaos Machairas, Ioannis A. Ziogas, Benedetto Mungo, Marco Del Chiaro, Georgios K. Glatzounis, Richard Schulick, and Georgios C. Sotiropoulos. "Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making." Cancers 18, no. 1 (2026): 94. https://doi.org/10.3390/cancers18010094.

MLA (9th ed.) Citation

Theocharopoulos, Charalampos, et al. "Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making." Cancers, vol. 18, no. 1, 2026, p. 94, https://doi.org/10.3390/cancers18010094.